Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa

BACKGROUND: Epidermolysis bullosa (EB) comprises inherited mechanobullous dermatoses with considerable morbidity and mortality. While current treatments are symptomatic, a growing number of innovative therapeutic compounds are evaluated in clinical trials. Clinical research in rare diseases like EB,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Orphanet J Rare Dis
Asıl Yazarlar: Prodinger, Christine, Diem, Anja, Ude-Schoder, Katherina, Piñón-Hofbauer, Josefina, Kitzmueller, Sophie, Bauer, Johann W., Laimer, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350741/
https://ncbi.nlm.nih.gov/pubmed/32650809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01443-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller